Efficacy of a Computerized Intervention on HIV and Intimate Partner Violence Among Substance-Using Women in Community Corrections: A Randomized Controlled Trial

Gilbert, Louisa; Goddard-Eckrich, Dawn; Hunt, Timothy; Ma, Xiaoguang; Chang, Mingway; Rowe, Jessica; McCrimmon, Tara; Johnson, Karen C.; Goodwin, Sharun; Almonte, Maria; Shaw, Stacey A.

doi:10.2105/ajph.2016.303119

Cited by 35 publications

(66 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on the information provided, facilitators identify existing ways in which women who use drugs have developed personalized coping strategies, solved problems and exhibited courage and determination [18]. Recent randomized controlled trials suggest that the programme is effective in reducing various forms of gender-based violence experienced by women who use drugs in the United States [19] and Kyrgyzstan [20], which is likely to have followon effects on HIV prevention [21]. In India, a preliminary pilot suggested that the intervention is feasible when delivered by other women who use drugs, and a pre-post evaluation indicated reductions in intimate partner and other violence victimization [22].…”

Section: Applying a Person-centred Lens To Hiv Preventionmentioning

confidence: 99%

Power to participants: a call for person‐centred HIV prevention services and research

Pantelic

Stegling

Shackleton³

et al. 2018

J Intern AIDS Soc

View full text Add to dashboard Cite

IntroductionWhile biomedical HIV prevention offers promise for preventing new HIV infections, access to and uptake of these technologies remain unacceptably low in some settings. New models for delivery of HIV prevention are clearly needed. This commentary highlights the potential of person‐centred programming and research for increasing the cultural relevance, applicability and use of efficacious HIV prevention strategies. It calls for a shift in perspective within HIV prevention programmes and research, whereby people are recognized for their agency rather than assumed to be passive beneficiaries or research participants.DiscussionPerson‐centred HIV prevention reorientates power dynamics so that individuals (rather than interventions) are at the centre of the response. Respecting personal choice and agency – and understanding how these are shaped by the context in which people exercise these choices – are critical dimensions of the person‐centred approach. Community‐based participatory research should be employed to inform and evaluate person‐centred HIV prevention. We argue that community‐based participatory research is an orientation rather than a method, meaning that it can be integrated within a range of research methods including randomized controlled trials. But embracing community‐based participatory approaches in HIV prevention research requires a systemic shift in how this type of research is reported in high impact journals and in how research impact is conceived. Community‐based organizations have a critical role to play in both person‐centred HIV prevention and research.Conclusions HIV prevention is situated at the intersection of unprecedented opportunity and crisis. Person‐centred approaches to HIV prevention and research shift power dynamics, and have the potential to ensure a more sustainable response with each individual actively participating in their own care and meaningfully contributing to the production of knowledge on HIV prevention. This approach taps into the resourcefulness, resilience and knowledge of the person and their communities, to strengthen research and programmes, making them more relevant, appropriate and effective.

show abstract

Section: Applying a Person-centred Lens To Hiv Preventionmentioning

confidence: 99%

Power to participants: a call for person‐centred HIV prevention services and research

Pantelic

Stegling

Shackleton³

et al. 2018

J Intern AIDS Soc

View full text Add to dashboard Cite

show abstract

“…Of the 1.2 million women convicted of a crime, only 15% are incarcerated; the remaining 85%, or approximately 1 million women each year, are sentenced to some form of community corrections (probation, parole, drug treatment court, alternative to incarceration) [ 13 , 15 , 16 ]. When compared with justice-involved women of other ethnicities and racial backgrounds, black women serving sentences in the community are more likely to engage in a variety of risky sexual behaviors, including having unprotected sex with paying partners, using illicit substances before and during sexual encounters, and trading sex for drugs [ 17 – 21 ].…”

Section: Introductionmentioning

confidence: 99%

“…Intertwined with the HIV/STI epidemic among substance-using black women who are involved in the criminal justice system is the co-occurring epidemic of intimate partner violence (IPV) [ 38 – 40 ]. Approximately 70% of substance-using black women in the 2009 trial of the multimedia WORTH intervention reported experiencing physical, sexual, and/or injurious IPV in their lifetime [ 21 ]. Abundant research has found that experiencing IPV is strongly associated with engaging in unprotected sex, having multiple sexual partners, testing positive for HIV/STIs, and failure to access and adhere to HIV treatment [ 41 – 45 ].…”

Section: Introductionmentioning

confidence: 99%

“…Abundant research has found that experiencing IPV is strongly associated with engaging in unprotected sex, having multiple sexual partners, testing positive for HIV/STIs, and failure to access and adhere to HIV treatment [ 41 – 45 ]. The multimedia WORTH intervention was found to be efficacious in reducing physical, sexual, and injurious IPV at the 12-month follow-up compared with the Wellness Promotion control group [ 21 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The effectiveness of a group-based computerized HIV/STI prevention intervention for black women who use drugs in the criminal justice system: study protocol for E-WORTH (Empowering African-American Women on the Road to Health), a Hybrid Type 1 randomized controlled trial

Johnson

Gilbert

Hunt

et al. 2018

Trials

Self Cite

View full text Add to dashboard Cite

BackgroundThis paper describes the study protocol of a hybrid type I randomized controlled trial that evaluates the effectiveness and cost-effectiveness of implementing Empowering African-American Women on the Road to Health (E-WORTH), an Afrocentric, group-based, computerized human immunodeficiency virus (HIV)/sexually transmitted infection (STI) prevention intervention for controlled substance-using black women in community corrections settings in New York City.Methods/designWe provide an overview of E-WORTH’s hybrid type I design, which is guided by the Consolidated Framework for Implementation Research (CFIR). E-WORTH combines HIV/STI and intimate partner violence (IPV) prevention components and tests the comparative effectiveness of E-WORTH and streamlined HIV testing versus streamlined HIV testing alone in decreasing biologically confirmed HIV and STI incidence, sexual risk, and IPV, as well as in improving access to HIV and STI prevention services and care.DiscussionThis paper provides an overview of E-WORTH’s intervention protocol and serves as a framework for using hybrid type I designs, guided by the CFIR conceptual framework, to evaluate HIV/STI and IPV prevention interventions in community corrections settings. We discuss how E-WORTH’s hybrid type I design advances implementation science through its effectiveness and cost-effectiveness aims as well as through a mixed-methods study that evaluates multilevel theory-driven factors (structural, organizational, staffing, and client) guided by the CFIR that influences the implementation of E-WORTH in a criminal justice setting. This study also addresses the novel challenges and opportunities of implementing an intervention that targets specific racial subgroup(s) in a community corrections setting that services all populations, implementing a group-based intervention with technological components in such settings, and employing community-based participatory research strategies to guide recruitment and retention efforts.Trial registrationClinicalTrials.gov, NCT02391233. Registered on 17 March 2015.Electronic supplementary materialThe online version of this article (10.1186/s13063-018-2792-3) contains supplementary material, which is available to authorized users.

show abstract

“…Although Department of Health and Human Services regulations such as the Health Insurance Portability and Accountability Act Privacy Rule (Standards for Privacy of Individually Identifiable Health Information, 2016) and regulations regarding the conduct of research with human subjects (Protection of Human Subjects, 2016) have standardized and mandated data handling practice (e.g., password protection and encryption) across clinical and research institutions, limited guidance is provided on safety when using hardware, software, and Internet and wireless technology with IPV research (Bloom et al, 2014; Garabedian, Ross-Degnan, & Wharam, 2015; Gilbert et al, 2016; Glass et al, 2015; Hegarty et al, 2015; Marcano Belisario et al, 2015). A second notable gap is the lack of guidance regarding determining and responding to research participant reports of risk for suicide and/or homicide during study activities and their preferences sharing this information to providers or receiving referrals to available services.…”

mentioning

confidence: 99%

Conducting Clinically Based Intimate Partner Violence Research

2017

View full text Add to dashboard Cite

Background Maintaining safety is of utmost importance during research involving participants who have experienced intimate partner violence (IPV). Limited guidance on safety protocols to protect participants is available, particularly information related to technology-based approaches to informed consent, data collection, and contacting participants during the course of a study. Purpose The purpose of the paper is to provide details on the safety protocol developed and utilized with women receiving care at an urban HIV clinic, and who were taking part in an observational study of IPV, mental health symptoms, and substance abuse and their relationship to HIV treatment adherence. The protocol presents the technological strategies to promote safety and allow autonomy in participant decision-making throughout the research process, including Voice over Internet Protocol telephone numbers, and tablet-based eligibility screening and data collection. Protocols for management of participants at risk for suicide and/or intimate partner homicide included automated high-risk messaging to participants and research staff and facilitated disclosure of risk to clinical staff based on participant preferences are discussed. Discussion Use of technology and partnership with clinic staff helped to provide an environment where research regarding IPV could be conducted without undue burden or risk to participants. Utilizing tablet-based survey administration provided multiple practical and safety benefits for participants. The majority of women who screened into high-risk categories for suicide or intimate partner homicide did not choose to have their results shared with their healthcare providers, indicating the importance of allowing participants control over information sharing whenever possible.

show abstract

Efficacy of a Computerized Intervention on HIV and Intimate Partner Violence Among Substance-Using Women in Community Corrections: A Randomized Controlled Trial

Abstract: The efficacy of Computerized WORTH across multiple IPV outcomes highlights the promise of integrating computerized, self-paced IPV prevention modules in HIV prevention groups.

Cited by 35 publications

References 38 publications

Power to participants: a call for person‐centred HIV prevention services and research

Power to participants: a call for person‐centred HIV prevention services and research

The effectiveness of a group-based computerized HIV/STI prevention intervention for black women who use drugs in the criminal justice system: study protocol for E-WORTH (Empowering African-American Women on the Road to Health), a Hybrid Type 1 randomized controlled trial

Conducting Clinically Based Intimate Partner Violence Research

Contact Info

Product

Resources

About